F. E. Preston

4.5k total citations
90 papers, 3.4k citations indexed

About

F. E. Preston is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, F. E. Preston has authored 90 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 25 papers in Cardiology and Cardiovascular Medicine and 14 papers in Genetics. Recurrent topics in F. E. Preston's work include Blood Coagulation and Thrombosis Mechanisms (17 papers), Platelet Disorders and Treatments (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). F. E. Preston is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (17 papers), Platelet Disorders and Treatments (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). F. E. Preston collaborates with scholars based in United Kingdom, United States and Netherlands. F. E. Preston's co-authors include M. Greaves, K. K. Hampton, C.W.I. Douglas, J. D. Ward, W R Timperley, J. Heath, J. H. Galloway, B C O'Malley, Ian J. Cartwright and R.G.G. Russell and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

F. E. Preston

88 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. E. Preston United Kingdom 31 1.1k 892 544 459 396 90 3.4k
Nils U. Bang United States 30 1.2k 1.1× 460 0.5× 362 0.7× 316 0.7× 185 0.5× 90 2.6k
N. Semeraro Italy 29 1.5k 1.3× 532 0.6× 557 1.0× 440 1.0× 152 0.4× 142 3.5k
G. P. McNicol United Kingdom 28 1.0k 0.9× 486 0.5× 370 0.7× 444 1.0× 205 0.5× 126 2.9k
Mario Colucci Italy 33 1.8k 1.6× 683 0.8× 594 1.1× 609 1.3× 181 0.5× 147 4.6k
Charles S. Eby United States 22 862 0.8× 754 0.8× 628 1.2× 385 0.8× 128 0.3× 61 3.0k
P. A. Owren Norway 20 1.1k 1.0× 633 0.7× 305 0.6× 303 0.7× 297 0.8× 49 2.7k
Walter A. Wuillemin Switzerland 37 1.8k 1.6× 1.1k 1.2× 1.0k 1.9× 665 1.4× 414 1.0× 130 4.6k
F. Haverkate Netherlands 32 1.8k 1.7× 1.1k 1.2× 558 1.0× 770 1.7× 152 0.4× 94 4.7k
Marı́a Luisa Lozano Spain 33 1.5k 1.3× 640 0.7× 208 0.4× 766 1.7× 140 0.4× 171 3.8k
Scott H. Goodnight United States 24 493 0.4× 472 0.5× 321 0.6× 698 1.5× 718 1.8× 60 2.5k

Countries citing papers authored by F. E. Preston

Since Specialization
Citations

This map shows the geographic impact of F. E. Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. E. Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. E. Preston more than expected).

Fields of papers citing papers by F. E. Preston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. E. Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. E. Preston. The network helps show where F. E. Preston may publish in the future.

Co-authorship network of co-authors of F. E. Preston

This figure shows the co-authorship network connecting the top 25 collaborators of F. E. Preston. A scholar is included among the top collaborators of F. E. Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. E. Preston. F. E. Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kitchen, Steve, Ian Jennings, F. E. Preston, et al.. (2009). Interlaboratory Variation in Factor VIII:C Inhibitor Assay Results Is Sufficient to Influence Patient Management: Data from the UK National Quality External Assessment Scheme for Blood Coagulation. Seminars in Thrombosis and Hemostasis. 35(8). 778–785. 27 indexed citations
2.
Rowan, R. M., Onno W. van Assendelft, & F. E. Preston. (2002). Advanced laboratory methods in haematology. 21 indexed citations
3.
Baglin, Trevor, Isobel D. Walker, Samuel J. Machin, et al.. (1998). Guidelines on oral anticoagulation: third edition. British Journal of Haematology. 101(2). 374–387. 248 indexed citations
4.
Goodeve, Anne, Giuseppe Tagariello, Ampaiwan Chuansumrit, F. E. Preston, & I R Peake. (1996). A rapid and cost effective method for analysis of dinucleotide repeat polymorphisms in the factor VIII gene. Blood Coagulation & Fibrinolysis. 7(7). 672–677. 18 indexed citations
5.
Ford, I., et al.. (1996). Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function. Diabetologia. 39(3). 336–343. 17 indexed citations
6.
Johnson, Brian F. G., et al.. (1994). URINARY THROMBOXANE AND 6-KETO-PROSTAGLANDIN F1α ARE EARLY MARKERS OF ACUTE REJECTION IN EXPERIMENTAL PANCREAS TRANSPLANTATION1. Transplantation. 58(1). 18–22. 4 indexed citations
7.
Beauchamp, Nicholas, Martina E. Daly, K. K. Hampton, et al.. (1994). High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. British Journal of Haematology. 88(1). 219–222. 121 indexed citations
8.
Dolan, G., Keith Neal, P. Cooper, Paula N. Brown, & F. E. Preston. (1994). Protein C, antithrombin III and plasminogen: effect of age, sex and blood group. British Journal of Haematology. 86(4). 798–803. 49 indexed citations
9.
Ford, I., et al.. (1993). Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. British Journal of Haematology. 84(1). 95–100. 35 indexed citations
10.
Johnson, Brian F. G., et al.. (1993). THROMBOXANE AND PROSTACYCLIN SYNTHESIS IN EXPERIMENTAL PANCREAS TRANSPLANTATION1. Transplantation. 56(6). 1447–1453. 8 indexed citations
11.
Giddings, J. C., M. Greaves, R A Hutton, et al.. (1991). Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.. Journal of Clinical Pathology. 44(11). 885–889. 59 indexed citations
12.
Greaves, M. & F. E. Preston. (1991). Clinical Annotation. THE HYPERCOAGULABLE STATE IN CLINICAL PRACTICE. British Journal of Haematology. 79(2). 148–151. 7 indexed citations
13.
Greaves, M., et al.. (1987). Potential value of vintristine‐adriamycin‐dexamethasone combination chemotherapy (VAD) in refractory and rapidly progressive myeloma. European Journal Of Haematology. 39(3). 203–208. 11 indexed citations
14.
Hutchinson, David, et al.. (1985). The routine measurement of platelet volume: a comparison of aperture-impedance and flow cytometric systems. Clinical & Laboratory Haematology. 7(3). 251–257. 25 indexed citations
15.
Woodcock, Barrie, et al.. (1984). Beneficial effect of fish oil on blood viscosity in peripheral vascular disease.. BMJ. 288(6417). 592–594. 123 indexed citations
16.
Davies-Jones, G.A.B., F. E. Preston, & W R Timperley. (1980). Neurological complications in clinical haematology. 7 indexed citations
17.
Preston, F. E., J.F. Martin, Ronald M. Stewart, & G.A.B. Davies-Jones. (1979). Thrombocytosis, circulating platelet aggregates, and neurological dysfunction.. BMJ. 2(6204). 1561–1563. 40 indexed citations
18.
Best, L., R.G.G. Russell, F. E. Preston, & T. John Martin. (1977). Responsiveness of adenylate cyclase in human blood platelets. Journal of Endocrinology. 73. 1 indexed citations
19.
Preston, F. E., et al.. (1974). Essential Thrombocythaemia and Peripheral Gangrene. BMJ. 3(5930). 548–552. 108 indexed citations
20.
Roberts, Darren M. & F. E. Preston. (1970). Skin Disease and the Gut. BMJ. 3(5721). 521.3–522. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nils U. Bang Breakdown of academic impact, for papers by N. Semeraro Breakdown of academic impact, for papers by G. P. McNicol Breakdown of academic impact, for papers by Mario Colucci Breakdown of academic impact, for papers by Charles S. Eby Breakdown of academic impact, for papers by P. A. Owren Breakdown of academic impact, for papers by Walter A. Wuillemin Breakdown of academic impact, for papers by F. Haverkate Breakdown of academic impact, for papers by Marı́a Luisa Lozano Breakdown of academic impact, for papers by Scott H. Goodnight
Rankless by CCL
2026